PHARMA DOCTOR


Compare international online pharmacies prices and services

Product Name: Sorafenib
Generic Name: Sorafenib
Common Brands: Nexavar, Sorafenat, Soranib
Pharmaceutical Categories: Cancer

Where to buy Sorafenib online:

Shop | Product | Forms | Strength | Conditions
MEDS FOR SALE
  • Nexavar tablets 200 mg
  • 5% discount coupon: 5OFF
  • Payment: Visa, Mastercard, AmEx, Bitcoin
  • Shipping: worldwide
  • Delivery: unregistered mail, trackable courier


  • Sorafenib (trade names include Nexavar, Sorafenat, Soranib, Soranix) is an anti-cancer drug from protein kinase inhibitors pharmacological group. This medication is used for the treatment of advanced primary liver cancer (hepatocellular carcinoma), primary kidney cancer (advanced renal cell carcinoma, advanced renal cancer), FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma. It is in researcj studies for the treatment of lung, brain (recurrent glioblastoma), ovarian cancer, desmoid tumor (aggressive fibromatosis). It works by inhibiting protein kinases enzymes in cancer cells.


    Nexavar (Sorafenib Tosylate) tablets


    Customers also buy these medications from the same pharmacological classes:

  • Acalabrutinib (Calquence)
  • Binimetinib (Mektovi)
  • Cediranib (Recentin)
  • Ceritinib (Zykadia)
  • Cobimetinib (Cotellic)
  • Dacomitinib (Vizimpro)
  • Dasatinib (Sprycel)
  • Erlotinib (Tarceva)
  • Exemestane (Aromasin)
  • Gilteritinib (Xospata)
  • Lorlatinib (Lorbrena)
  • Masitinib (Masivet)
  • Osimertinib (Tagrisso)
  • Ruxolitinib (Jakafi)
  • Temsirolimus (Torisel)
  • Trametinib (Mekinist)
  • Vandetanib (Caprelsa)
  • Vemurafenib (Zelboraf)


    Pharmaceutical and medical classifications:

  • Angiogenesis inhibitors
  • Anti cancer drugs
  • Anti tumor medicines
  • Cytostatic agents
  • Medications for the treatment of liver tumors
  • Tyrosine kinase inhibitors


    The Anatomical Therapeutic Chemical (ATC) classification system (developed by the World Health Organization):

  • L - Antineoplastic and immunomodulating agents
  • L01 - Antineoplastic agents
  • L01X - Other antineoplastic agents
  • L01XE - Protein kinase inhibitors
  • L01XE05 - Sorafenib


    Medical conditions for sorafenib in the International Statistical Classification of Diseases and Related Health Problems:

  • Malignant neoplasm of liver and intrahepatic bile ducts - C22
  • Liver cell carcinoma - C22.0
  • Malignant neoplasm of bronchus and lung - C34
  • Malignant neoplasm of ovary - C56
  • Malignant neoplasm of kidney, except renal pelvis - C64
  • Malignant neoplasm of brain - C71
  • Malignant neoplasm of thyroid gland - C73
  • Neoplasm of uncertain behavior of other and unspecified sites - D48
  • Fibroblastic disorders - M72


    Pregnancy category:

  • D - Australia
  • D - United States (Positive evidence of risk)


    Forms of active pharmaceutical ingredients (APIs):

  • Sorafenib Base
  • Sorafenib Tosylate


    Chemical, international, and other names of this drug:

  • Sorafenibi
  • Sorafenibum
  • Sorafeniib


    Most known trade names (brands and generics) worldwide:

  • Nexavar - Bayer, Onyx Pharmaceuticals
  • Sorafenat - Natco Pharma
  • Soranib - Cipla
  • Soranix - Beacon Pharmaceuticals


    References and external sources:

  • Sorafenib main article on Wikipedia: https://en.wikipedia.org/wiki/Sorafenib
  • Sorafenib compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Sorafenib
  • Sorafenib Tosylate compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Sorafenib-tosylate
  • Sorafenib medicine on DrugBank: https://www.drugbank.ca/drugs/DB00398
  • Sorafenib Tosylate on DrugBank: https://www.drugbank.ca/salts/DBSALT000165
  • Sorafenib FAQ on MedlinePlus (revised 02/15/2019): https://medlineplus.gov/druginfo/meds/a607051.html
  • Nexavar (Sorafenib Tosylate) film-coated tablets drug label on DailyMed (revised July 9, 2020): https://dailymed.nlm.nih.gov/dailymed/lookup...
  • Nexavar (Sorafenib Tosylate) tablets for oral use official prescribing and patient information from the U.S. FDA (revised 07/2020): https://www.accessdata.fda.gov/drugsatfda_docs/label...
  • Nexavar (Sorafenib Tosylate) tablets 200 mg product monograph from Bayer pharmaceutical company (revised 07/2020): https://www.bayer.com/sites/default/files/...
  • Nexavar (Sorafenib Tosylate) tablets official website powered by Bayer (for U.S. audiences only): https://www.nexavar-us.com/
  • Nexavar (Sorafenib Tosylate) tablets official website for healthcare professionals (for U.S. audiences only): https://www.hcp.nexavar-us.com/
  • Nexavar (Sorafenib Tosylate) 200 mg film-coated tablets package information leaflet Medicines.org.uk (revised 09/2019): https://www.medicines.org.uk/emc/files/pil.226.pdf
  • Soranib (Sorafenib Tosylate, Nexavar generic) 200 mg film-coated tablets prescribing information from Cipla company (revised December 2017): https://www.ciplamed.com/content/soranib-tablets

    Revised: May 2022



  • Disclaimer: Please note, this website is not an online pharmacy, drugstore and related online pharma shop. It does not sell, supply or advertise any prescription and OTC drugs, medications, other goods and services. All reviews, links, lists, databases, texts, and other content on the website are provided free and only for informational and educational purposes. Medical content on this website, including drug names, indications, contraindication, side effects, categories, classifications, forms, doses, prices, other health and pharmaceutical information are taken only from trusted and authoritative professional sources (see "References"), reviewed and prepared by our licensed experts, content inspectors and editors.
    You should always consult your doctor or other healthcare professional before using any medication. This website, our staff and support do not provide own medical instructions and advices.
    All brands and trade names appearing on the website are registered trademarks and intellectual property of their respective companies.
    Remember that buying drugs and medicines online is a responsibility only of customers, sellers and suppliers regarding existing legislation in their jurisdictions.

    Share us in social media:

    Home | Sitemap | Privacy Policy | Cookies Policy | Terms of Service | References | Contact Us

    Copyright © 2007 - 2022 Pharma-Doctor.com. All rights reserved.